These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2344373)
1. Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency. Radparvar S; Houghton PJ; Germain G; Pennington J; Rahman A; Houghton JA Biochem Pharmacol; 1990 Jun; 39(11):1759-65. PubMed ID: 2344373 [TBL] [Abstract][Full Text] [Related]
2. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells. Houghton JA; Morton CL; Adkins DA; Rahman A Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921 [TBL] [Abstract][Full Text] [Related]
3. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells. Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189 [TBL] [Abstract][Full Text] [Related]
4. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells. Geoffroy FJ; Allegra CJ; Sinha B; Grem JL Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251 [TBL] [Abstract][Full Text] [Related]
5. Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma. Benz C; Choti M; Newcomer L; Cadman E Cancer Chemother Pharmacol; 1984; 12(2):104-10. PubMed ID: 6199130 [TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine. Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045 [TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452 [TBL] [Abstract][Full Text] [Related]
8. Monitoring of the intracellular activation of 5-fluorouracil to deoxyribonucleotides in HT29 human colon cell line: application to modulation of metabolism and cytotoxicity study. Ciccolini J; Peillard L; Aubert C; Formento P; Milano G; Catalin J Fundam Clin Pharmacol; 2000; 14(2):147-54. PubMed ID: 10796062 [TBL] [Abstract][Full Text] [Related]
9. Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects. Lawrence TS; Davis MA; Maybaum J Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):519-23. PubMed ID: 8005809 [TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas. Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226 [TBL] [Abstract][Full Text] [Related]
11. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil. Berger SH; Hakala MT Mol Pharmacol; 1984 Mar; 25(2):303-9. PubMed ID: 6608049 [TBL] [Abstract][Full Text] [Related]
12. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112 [TBL] [Abstract][Full Text] [Related]
13. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells. Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a human colon adenocarcinoma xenograft deficient in thymidine salvage. Houghton PJ; Houghton JA; Germain G; Torrance PM Cancer Res; 1987 Apr; 47(8):2117-22. PubMed ID: 3829001 [TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts. Ciccolini J; Peillard L; Evrard A; Cuq P; Aubert C; Pelegrin A; Formento P; Milano G; Catalin J Clin Cancer Res; 2000 Apr; 6(4):1529-35. PubMed ID: 10778986 [TBL] [Abstract][Full Text] [Related]
16. Synergistic cytotoxic effect between serine-threonine phosphatase inhibitors and 5-fluorouracil: a novel concept for modulation of cytotoxic effect. Islam MM; Begum S; Lin L; Okamura A; Du M; Fujimura S Cancer Chemother Pharmacol; 2002 Feb; 49(2):111-8. PubMed ID: 11862424 [TBL] [Abstract][Full Text] [Related]
17. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8. Darnowski JW; Goulette FA Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649 [TBL] [Abstract][Full Text] [Related]
18. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole. Grem JL; Fischer PH Cancer Res; 1985 Jul; 45(7):2967-72. PubMed ID: 4005834 [TBL] [Abstract][Full Text] [Related]
19. Relationship between 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas. Houghton JA; Weiss KD; Williams LG; Torrance PM; Houghton PJ Biochem Pharmacol; 1986 Apr; 35(8):1351-8. PubMed ID: 3008760 [TBL] [Abstract][Full Text] [Related]
20. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells. Tillman DM; Petak I; Houghton JA Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]